EnteroMedics Inc. (NASDAQ: ETRM) today announced clinical results from two studies of VBLOC vagal blocking therapy, including additional data from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE